COVID-19 cases rise in Georgia. Here’s why this wave is different –  The Atlanta Journal Constitution
                            June 26, 2024
                                And while the rise is not    too surprising with people traveling and gathering indoors    where its cooler, health experts and doctors expect this    seasons illnesses to be milder than some past versions of the    virus. But the latest iterations of the ever-evolving    coronavirus seem to be more contagious.  
    Dr. Luke Lathrop, chief    medical officer at     SmartMED Drive-Thru Medical Care in Roswell, said he has    seen a small but notable rise in COVID cases in recent days.    Of the roughly 30 patients seen there Monday, seven tested    positive for the virus. Thats up from one or two a day in    recent months.  
          Credit: custom        
      Credit: custom    
    Symptoms from the latest variants circulating are familiar and    include sore throat, runny nose, coughing, head and body aches,    fever, fatigue, and in more severe cases, shortness of breath.  
    For many people who have already had COVID, a reinfection is    often milder than an earlier case. But people who are 65 and    older, pregnant or immunocompromised remain at higher risk of    serious complications from COVID. Lathrop said he has sent a    few older patients with COVID to the ER due to their low oxygen    levels.  
    I think the early predictions from the experts and the CDC    were right on in that it seems to be ending up like being    another influenza where there will be some seasonality to it,    said Lathrop. The symptoms overlap and some people get very    ill. And for some people, its a mild cold.  
    So its almost like a new flu out there and its not going    away. We are going to have to deal with it, said Lathrop. It    affects everybody in different ways.  
    While ER visits for COVID increased 14.7% in the past week    nationally, they still only account for 0.7% of ER visits,    according to CDC. In Georgia, the share of COVID patients in    the ER is even lower.  
    Since April, less than 0.5% of emergency department patients in    Georgia were diagnosed with COVID. Thats in line with last    years trend, which saw an increase during the months of July    and August.  
    This is a far cry from past summer peaks. During last summers    peak, 2.5% of emergency department patients were diagnosed with    COVID. COVID accounted for 3.5% of emergency patients in 2022,    and 7% during the summer of 2021.  
          Credit: AP        
      Credit: AP    
    Experts say the COVID vaccines still provide some protection    but their protection wanes over time. The latest variants have    mutations thought to make it easier for them to evade immunity    among people who received the most recent updated vaccine or    who were infected several months ago.  
          Credit: Contributed        
      Credit: Contributed    
    Dr. Jayne Morgan, executive director of health and community    education for Piedmont Healthcare, said the new JN.1 variant is    both stealthy and contagious, but overall the symptoms remain    mild.  
    This could result in more infections with mild symptoms and    with many of these illnesses being ignored or dismissed as    another virus. While some will continue to be hit hard by the    virus, the upside to a mild yet contagious virus is that it    could boost immunity levels in the general population, she    said.  
    The CDC recommended people over 65 who already had one dose of    the updated vaccine get an additional shot at least four months    later. Doctors say vaccines remain the best way to protect    against the worst outcomes of COVID.  
    For now, the publics interest in updated COVID vaccines has    been cool. According to the CDC, as of May 11, only 22% of    adults reported having received an updated 2023-24 vaccine    since September 14, 2023.  
    In a new poll of 1,000 likely voters conducted by The Atlanta    Journal-Constitution this month asking how much of a threat the    coronavirus poses to the nation, 47% of respondents said it was    a minor threat, while only 13% considered it a major    threat.  
    In addition, health officials say getting the vaccine formula    and production schedule just right can be tricky.  
    The Food and Drug Administration recently    decided to request drug makers update the COVID vaccines to    target the KP.2 strain, a descendent of the JN.1 variant that    started circulating widely in the U.S. over the winter months.    The announcement came a week after an FDA advisory panel voted    unanimously to recommend the fall vaccine be designed to target    the JN.1 variant or one of its descendants.  
    Dr. Peter Marks, director for FDAs Center for Biologics    Evaluation and Research, said last week during a discussion    about seasonal flu and COVID vaccines that his agency and the    CDC work to follow the evolution of the coronavirus in order to    update the COVID vaccine formula.  
    The optimal protection is making sure we get closest to what    is actually circulating, he said.  
    Early this year the JN.1 (omicron) variant was circulating, but    as the FDA and CDC got closer to the time when they needed to    choose a strain to include in this falls vaccine, other    descendants of JN.1 began to appear.  
    Now public health experts are hoping to formulate the shot to    target one of those variants  KP.2. But even that variant is    already being outpaced by another offshoot, KP.3.  
    And then, by the time fall rolls around and the COVID boosters    are made available, the updated vaccine might have lost some of    its effectiveness against the mutating virus.  
    Despite these difficulties, public health officials say a fall    rollout of the vaccine still seems to make the most sense.  
    Its anticipated that COVID will, over time, settle into a more    traditional seasonal pattern in line with other respiratory    viruses, with seasonal peaks in the fall and winter months,    according to Morgan.  
    But the reality is because the coronavirus evolves so rapidly    and doesnt retreat as weather warms, immunity to COVID may not    last until the following fall and winter season, lending to    the current summer increases that we see, she said.  
    Data reporter Stephanie Lamm contributed to this    article.  
    So youve got COVID and arent sure whether to stay home? The    Centers for Disease Control and Prevention in March updated its    guidelines on when people can return to their normal activities    after any viral illness such as the flu or COVID.  
    You can go back to your normal activities when, for at least 24    hours, both are true:  
    o Your symptoms are getting better overall, and  
    o You have not had a fever (and are not using fever-reducing    medication).  
    When you go back to your normal activities, take added    precautions over the next 5 days, such as taking additional    steps for cleaner air, hygiene, masks, physical distancing, and    testing yourself when you will be around other people indoors.  
    o Keep in mind that you may still be able to spread the virus    that made you sick, even if you are feeling better. You are    likely to be less contagious at this time, depending on factors    like how long you were sick or how sick you were.  
    o If you develop a fever or you start to feel worse after you    have gone back to normal activities, stay home and away from    others again until, for at least 24 hours your symptoms are    improving overall, and you have not had a fever (and are not    using fever-reducing medication). Then take added precautions    for the next 5 days.  
More here:
COVID-19 cases rise in Georgia. Here's why this wave is different -  The Atlanta Journal Constitution